Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
Genomics-based immunological risk stratification in kidney transplantation
Dauer: 36 Monate, Fördersumme: € 899.840
Combating Viral Susceptibility in Premature Infants
Dauer: 36 Monate, Fördersumme: € 738.030
Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice
Dauer: 48 Monate, Fördersumme: € 799.570
A novel macrophage precursor in adult bone marrow
Dauer: 48 Monate, Fördersumme: € 798.940
Beyond lipid lowering - defining residual risk of cardiovascular events
Dauer: 61 Monate, Fördersumme: € 736.660